No Data
Catalyst Watch: Bank Earnings, Oil Updates, Powerhouse Conferences in Retail and Healthcare
Pulse Biosciences Pickes Former Boston Scientific Exec as New CEO
Today's Analyst Rating | Deutsche Bank Upgrades Boston Scientific to Buy, Morgan Stanley Upgrades Gilead Sciences to Buy
Jan 10, Wall Street analysts have updated their stock ratings today including $Boston Scientific(BSX.US)$ and $Gilead Sciences(GILD.US)$.
Deutsche Bank Upgrades Boston Scientific(BSX.US) to Buy Rating, Raises Target Price to $108
Buy Rating for Boston Scientific Driven by Strong PFA Technology Adoption and Market Dynamics
Express News | Boston Scientific : Deutsche Bank Raises Target Price to $108 From $87